215 related articles for article (PubMed ID: 38812061)
1. Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.
Pedicone C; Weitzman SA; Renton AE; Goate AM
Mol Neurodegener; 2024 May; 19(1):43. PubMed ID: 38812061
[TBL] [Abstract][Full Text] [Related]
2. Recurrent inversion events at 17q21.31 microdeletion locus are linked to the MAPT H2 haplotype.
Rao PN; Li W; Vissers LE; Veltman JA; Ophoff RA
Cytogenet Genome Res; 2010; 129(4):275-9. PubMed ID: 20606400
[TBL] [Abstract][Full Text] [Related]
3. Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner.
de Jong S; Chepelev I; Janson E; Strengman E; van den Berg LH; Veldink JH; Ophoff RA
BMC Genomics; 2012 Sep; 13():458. PubMed ID: 22950410
[TBL] [Abstract][Full Text] [Related]
4. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
5. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
[TBL] [Abstract][Full Text] [Related]
6. Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and
Wang H; Chang TS; Dombroski BA; Cheng PL; Si YQ; Tucci A; Patil V; Valiente-Banuet L; Farrell K; Mclean C; Molina-Porcel L; Alex R; Paul De Deyn P; Le Bastard N; Gearing M; Donker Kaat L; Van Swieten JC; Dopper E; Ghetti BF; Newell KL; Troakes C; G de Yébenes J; Rábano-Gutierrez A; Meller T; Oertel WH; Respondek G; Stamelou M; Arzberger T; Roeber S; Müller U; Hopfner F; Pastor P; Brice A; Durr A; Ber IL; Beach TG; Serrano GE; Hazrati LN; Litvan I; Rademakers R; Ross OA; Galasko D; Boxer AL; Miller BL; Seeley WW; Van Deerlin VM; Lee EB; White CL; Morris HR; de Silva R; Crary JF; Goate AM; Friedman JS; Leung YY; Coppola G; Naj AC; Wang LS; ; Dickson DW; Höglinger GU; Tzeng JY; Geschwind DH; Schellenberg GD; Lee WP
medRxiv; 2024 Feb; ():. PubMed ID: 38464214
[TBL] [Abstract][Full Text] [Related]
7. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
[TBL] [Abstract][Full Text] [Related]
8. Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes.
Koks S; Pfaff AL; Bubb VJ; Quinn JP
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804213
[TBL] [Abstract][Full Text] [Related]
9. Using the neanderthal and denisova genetic data to understand the common MAPT 17q21 inversion in modern humans.
Setó-Salvia N; Sánchez-Quinto F; Carbonell E; Lorenzo C; Comas D; Clarimón J
Hum Biol; 2012 Dec; 84(6):633-40. PubMed ID: 23959642
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
11. From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.
Kalinderi K; Fidani L; Bostantjopoulou S
Parkinsonism Relat Disord; 2009 Jan; 15(1):2-5. PubMed ID: 18424220
[TBL] [Abstract][Full Text] [Related]
12. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
13. Structural diversity and African origin of the 17q21.31 inversion polymorphism.
Steinberg KM; Antonacci F; Sudmant PH; Kidd JM; Campbell CD; Vives L; Malig M; Scheinfeldt L; Beggs W; Ibrahim M; Lema G; Nyambo TB; Omar SA; Bodo JM; Froment A; Donnelly MP; Kidd KK; Tishkoff SA; Eichler EE
Nat Genet; 2012 Jul; 44(8):872-80. PubMed ID: 22751100
[TBL] [Abstract][Full Text] [Related]
14. Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.
Hardy J; Pittman A; Myers A; Gwinn-Hardy K; Fung HC; de Silva R; Hutton M; Duckworth J
Biochem Soc Trans; 2005 Aug; 33(Pt 4):582-5. PubMed ID: 16042549
[TBL] [Abstract][Full Text] [Related]
15. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
16. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.
Caffrey TM; Wade-Martins R
Neurobiol Dis; 2007 Jul; 27(1):1-10. PubMed ID: 17555970
[TBL] [Abstract][Full Text] [Related]
17. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.
Oliveira SA; Scott WK; Zhang F; Stajich JM; Fujiwara K; Hauser M; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
Neurogenetics; 2004 Sep; 5(3):147-55. PubMed ID: 15459824
[TBL] [Abstract][Full Text] [Related]
18. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
19. Neolithic expansion and the 17q21.31 inversion in Iberia: an evolutionary approach to H2 haplotype distribution in the Near East and Europe.
Espinosa I; Alfonso-Sánchez MA; Gómez-Pérez L; Peña JA
Mol Genet Genomics; 2023 Jan; 298(1):153-160. PubMed ID: 36355195
[TBL] [Abstract][Full Text] [Related]
20. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.
Bowles KR; Pugh DA; Liu Y; Patel T; Renton AE; Bandres-Ciga S; Gan-Or Z; Heutink P; Siitonen A; Bertelsen S; Cherry JD; Karch CM; Frucht SJ; Kopell BH; Peter I; Park YJ; ; Charney A; Raj T; Crary JF; Goate AM
Mol Neurodegener; 2022 Jul; 17(1):48. PubMed ID: 35841044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
